Success Metrics

Clinical Success Rate
25.0%

Based on 1 completed trials

Completion Rate
25%(1/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
3(75%)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(3)

Detailed Status

Terminated3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
25.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated375%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
terminated

Whole Body Hyperthermia Registry Study

NCT02174003
completednot_applicable

The Brain on Whole Body Hyperthermia: A Neuroimaging Study

NCT02062840
terminatednot_applicable

Whole Body Hyperthermia & Combat-Related Posttraumatic Stress Disorder (PTSD)

NCT02077972
terminatednot_applicable

Enhancing Psychotherapy for Mood Disorders With Whole Body Hyperthermia

NCT02021149

Clinical Trials (4)

Showing 4 of 4 trials
NCT02174003

Whole Body Hyperthermia Registry Study

Terminated
NCT02062840Not Applicable

The Brain on Whole Body Hyperthermia: A Neuroimaging Study

Completed
NCT02077972Not Applicable

Whole Body Hyperthermia & Combat-Related Posttraumatic Stress Disorder (PTSD)

Terminated
NCT02021149Not Applicable

Enhancing Psychotherapy for Mood Disorders With Whole Body Hyperthermia

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4